HCW Biologics Inc. (NASDAQ: HCWB) reported Q2 EPS of ($0.10), $0.04 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $454 thousand versus the consensus estimate of $0 .

For earnings history and earnings-related data on HCW Biologics Inc. (HCWB) click here.